FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2806715144> ?p ?o ?g. }

• W2806715144 endingPage "e50" @default.
• W2806715144 startingPage "e49" @default.
• W2806715144 abstract "Objective: Poor adherence to drug therapy is one of the most common factor explaining a poor blood pressures (BP) control in patients with apparent resistant hypertension. Few studies have used a standardized treatment coupled to electronic adherence monitoring in patients with apparent resistant hypertension. The objective of this study was to determine the rate of BP control when prescribing a standardized triple therapy associated with electronic monitoring of drug intake for 3 months and assessing BP control using 24 h ambulatory BP monitoring (ABPM). Design and method: Patients with 3 antihypertensive drugs and residual hypertension on 24 hr ABPM (excluding white coat hypertension) were recruited. A single pill combination of olmesartan 40 mg and amlodipine 10 mg was prescribed together with 25 mg chlorthalidone for 3 months. Medications were provided in 2 separated electronic pills boxes (MEMS®) recording the date and time of each opening. Patients were seen at 6 and 12 weeks. At 3 months, we analyzed MEMS® data and performed a second ABPM. Results: 49 patients (36% women) were included: 36 had complete data sets. Mean age was 56.5 ± 11.9 y, BMI was 31.2 ± 5.1 kg/m2. Overall, mean 24 h systolic BP (SBP) decreased from 148 ± 19 mmHg to 129 ± 16 mmHg (p < 0.001) and diastolic BP (DBP) decreased from 89.0 ± 16.1 mmHg to 77.5 ± 10.5 mmHg (p < 0.001). Overall 50 % of patients normalized SBP and 36% normalized both SBP and DBP. Median taking adherence (%) was respectively 92.5 % (interquartile range (IQR) 84.0–100) and 91.9 % (IQR 83.0–100) for the fixed combination and chlorthalidone. When analyzed according to tertiles of adherence, decreases in SBP were respectively 27 ± 16.6 mmHg in tertile 1 (99–100%), 20 ± 31 mmHg in tertile 2 (89–98.9%) and 9.1 ± 15.4 mmHg. in tertile 3 (0–88%) (p = 0.027 for trend). Conclusions: A simplified standardized antihypertensive therapy together with an electronic monitoring of adherence enables to normalize BP in more than 1/3 of patients with apparent resistant hypertension and no white coat effect. BP reduction correlates with the level of adherence. This diagnostic and supportive strategy may prevent from expensive and unnecessary investigations." @default.
• W2806715144 created "2018-06-13" @default.
• W2806715144 creator A5010136538 @default.
• W2806715144 creator A5046604334 @default.
• W2806715144 creator A5056380138 @default.
• W2806715144 creator A5060710329 @default.
• W2806715144 creator A5064438341 @default.
• W2806715144 creator A5070800289 @default.
• W2806715144 creator A5083320676 @default.
• W2806715144 date "2018-06-01" @default.
• W2806715144 modified "2023-10-18" @default.
• W2806715144 title "A STANDARDIZED TRIPLE THERAPY COMBINED WITH ELECTRONIC MONITORING OF ADHERENCE NORMALIZES 24 H ABPM IN AT LEAST ONE THIRD OF PATIENTS WITH RESISTANT HYPERTENSION" @default.
• W2806715144 doi "https://doi.org/10.1097/01.hjh.0000539096.20044.29" @default.
• W2806715144 hasPublicationYear "2018" @default.
• W2806715144 type Work @default.
• W2806715144 sameAs 2806715144 @default.
• W2806715144 citedByCount "0" @default.
• W2806715144 crossrefType "journal-article" @default.
• W2806715144 hasAuthorship W2806715144A5010136538 @default.
• W2806715144 hasAuthorship W2806715144A5046604334 @default.
• W2806715144 hasAuthorship W2806715144A5056380138 @default.
• W2806715144 hasAuthorship W2806715144A5060710329 @default.
• W2806715144 hasAuthorship W2806715144A5064438341 @default.
• W2806715144 hasAuthorship W2806715144A5070800289 @default.
• W2806715144 hasAuthorship W2806715144A5083320676 @default.
• W2806715144 hasConcept C119060515 @default.
• W2806715144 hasConcept C126322002 @default.
• W2806715144 hasConcept C149323552 @default.
• W2806715144 hasConcept C164705383 @default.
• W2806715144 hasConcept C2778281030 @default.
• W2806715144 hasConcept C2779646130 @default.
• W2806715144 hasConcept C2779766728 @default.
• W2806715144 hasConcept C71924100 @default.
• W2806715144 hasConcept C84393581 @default.
• W2806715144 hasConceptScore W2806715144C119060515 @default.
• W2806715144 hasConceptScore W2806715144C126322002 @default.
• W2806715144 hasConceptScore W2806715144C149323552 @default.
• W2806715144 hasConceptScore W2806715144C164705383 @default.
• W2806715144 hasConceptScore W2806715144C2778281030 @default.
• W2806715144 hasConceptScore W2806715144C2779646130 @default.
• W2806715144 hasConceptScore W2806715144C2779766728 @default.
• W2806715144 hasConceptScore W2806715144C71924100 @default.
• W2806715144 hasConceptScore W2806715144C84393581 @default.
• W2806715144 hasIssue "Supplement 1" @default.
• W2806715144 hasLocation W28067151441 @default.
• W2806715144 hasOpenAccess W2806715144 @default.
• W2806715144 hasPrimaryLocation W28067151441 @default.
• W2806715144 hasRelatedWork W181687752 @default.
• W2806715144 hasRelatedWork W1978501380 @default.
• W2806715144 hasRelatedWork W2034404561 @default.
• W2806715144 hasRelatedWork W2042358215 @default.
• W2806715144 hasRelatedWork W2053932973 @default.
• W2806715144 hasRelatedWork W2057768832 @default.
• W2806715144 hasRelatedWork W2352795911 @default.
• W2806715144 hasRelatedWork W2385764522 @default.
• W2806715144 hasRelatedWork W2549469951 @default.
• W2806715144 hasRelatedWork W3037878492 @default.
• W2806715144 hasVolume "36" @default.
• W2806715144 isParatext "false" @default.
• W2806715144 isRetracted "false" @default.
• W2806715144 magId "2806715144" @default.
• W2806715144 workType "article" @default.